This paper describes the Adverse Drug Reaction Reporting Program developed and operated by the Committee on Drugs and Pharmaco-therapy of the Ontario Medical Association. Analyses were done to demonstrate some of the trends derived from the reports. Some of the clinical observations based on the reports, which are published quarterly and circulated to physicians and to pharmacy, nursing and hospital organizations, are also reviewed.
Notes
Cites: N Engl J Med. 1974 Aug 8;291(6):302-34407113
Cites: JAMA. 1975 Dec 22;234(12):1236-411242749
Cites: JAMA. 1976 AUG 9;236(6):575-8947238
Cites: Can Med Assoc J. 1978 Dec 9;119(11):1315-6, 1319737607
Cites: Ann Intern Med. 1979 Feb;90(2):257-61443660
Cites: Can Med Assoc J. 1979 May 19;120(10):1200-1445256
Cites: Can Med Assoc J. 1984 Aug 1;131(3):189-916744164